Nature GeneticsGenomicsPeer-reviewed journal article
Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia
Derek H. JanssensiD, Michael P. MeersiD, Steven J. WuiD, Ekaterina Babaeva, Soheil MeshinchiiD, Jay F. SarthyiD, Kami AhmadiD, Steven HenikoffiD
Abstract
Acute myeloid and lymphoid leukemias often harbor chromosomal translocations involving the Mixed Lineage Leukemia-1 gene, encoding the KMT2A lysine methyltransferase. The most common translocations produce in-frame fusions of KMT2A to other chromatin regulatory proteins. Here we develop a strategy to map the genome-wide occupancy of oncogenic KMT2A fusion proteins in primary patient samples regardless of fusion partner. By modifying the versatile CUT&Tag method for full automation we identify common and tumor-specific patterns of aberrant chromatin regulation induced by different KMT2A fusion proteins. Integration of automated and single-cell CUT&Tag uncovers epigenomic heterogeneity within patient samples and predicts sensitivity to therapeutic agents.
- organism: human
- assay: ChIP-seq
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 87
- FWCI
- 4.31
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- KMT2A oncoproteins induce epigenetic resistance to targeted therapies
D. H. Janssens, M. Duran, … S. Henikoff·bioRxiv·Dec 29, 2023
- DNMT1-Mediated Epigenetic Reprogramming Drives KMT2A Amplifications and Rearrangements
Madison A. Lineberger, Zach H. Gray, … Johnathan R. Whetstine·bioRxiv·Sep 22, 2026
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients
Alastair Smith, Nicholas Denny, … Thomas A. Milne·BloodPeer-reviewed·Jul 29, 2025
- Chromatin Profiling of CBFA2T3-GLIS2 AMLs Identifies Key Transcription Factor Dependencies and BRG1 Inhibition as a Novel Therapeutic Strategy
S. Kaonis, J. L. Smith, … J. F. Sarthy·bioRxiv·Aug 30, 2023
- The nuclear oncoprotein SET is necessary for MLL/KMT2A binding and transcriptional elongation.
María-Paz García-Cuéllar, Robert K. Slany·bioRxiv·Feb 28, 2026
- Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers
Anna Stroynowska-Czerwińska, Magdalena Klimczak, … Matthias Bochtler·Cellular and Molecular Life SciencesPeer-reviewed·Jan 1, 2023